SEOUL, South Korea, July 24, 2026 — Jeisys Medical, a global medical aesthetic device leader, today announced that cumulative domestic shipments of its flagship radiofrequency (RF) device, Density, surpassed 1,000 units as of June 2026.
 

Reaching the 1,000-unit milestone within approximately three years of its April 2023 commercial launch underscores Density's rapid integration into South Korea's highly competitive medical aesthetic market. The achievement reflects a sustained rise in physician and patient demand for non-invasive, precision-driven skin rejuvenation procedures.
 

The platform's growth trajectory is further reinforced by the rapid commercial uptake of its latest disposable tip line. Launched in January, Density’s third-generation Alpha Tip reached 10,000 units supplied within three months and surpassed 20,000 units by month four, maintaining strong supply momentum through the second quarter.
 

The Alpha Tip features an expanded electrode surface area engineered to deliver both monopolar and bipolar RF energy seamlessly within a single treatment session, offering practitioners enhanced procedural flexibility and optimized energy delivery.
 

"Surpassing 1,000 domestic shipments of Density is a key business milestone that reflects the clinical trust earned from dermatologists and aesthetic physicians since launch," said a spokesperson for Jeisys Medical. "Building on this momentum and the rapid adoption of the Alpha Tip, we will continue expanding our global and domestic footprint with advanced energy-based portfolio innovations.